AEON Biopharma, Inc. - Class A Common Stock, par value $0.0001 per share (AEON)

28 filings reported holding AEON - AEON Biopharma, Inc. - Class A Common Stock, par value $0.0001 per share as of Q1 2024.
AEON Biopharma, Inc. - Class A Common Stock, par value $0.0001 per share (AEON) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.47M shares of 11.3M outstanding shares and own 83.71% of the company stock.
Largest 10 shareholders include Polar Asset Management Partners Inc. (3.68M shares), Atalaya Capital Management LP (3.68M shares), VANGUARD GROUP INC (759K shares), Ikarian Capital, LLC (258K shares), BlackRock Inc. (255K shares), GEODE CAPITAL MANAGEMENT, LLC (180K shares), GOLDMAN SACHS GROUP INC (169K shares), Formidable Asset Management, LLC (68.2K shares), Qube Research & Technologies Ltd (59.8K shares), and STATE STREET CORP (59.6K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.